Skip to main content
Terug
Watch Compare

SRx Health Solutions, Inc.

Datakwaliteit: 100%
SRXH
NYSE Manufacturing Food Products
€ 0,14
▲ € 0,00 (2,31%)
Marktkapitalisatie: 49,23 M
Prijs
€ 0,14
Marktkapitalisatie
49,23 M
Dagbereik
€ 0,13 — € 0,14
52-Weeksbereik
€ 0,08 — € 2,02
Volume
25.302.690
Openen € 0,13
50D / 200D Gem.
€ 0,13
3,46% above
50D / 200D Gem.
€ 0,31
55,48% below

Quick Summary

Belangrijkste Punten

Revenue declined -38,61% annually over 5 years
Negative free cash flow of -11,44 M
Revenue growth is decelerating — 1Y growth trails 5Y average by 42,71%

Groei

Revenue Growth (5Y)
-38,61%
Onder sectorgemiddelde (1,82%)
Revenue (1Y)-81,32%
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Kwaliteit

Return on Equity
N/A
ROICN/A
Net Margin-646,80%
Op. Margin-173,30%

Veiligheid

Debt / Equity
N/A
Current Ratio0,80
Interest Coverage-7,70

Waardering

PE (TTM)
-0,93
Boven sectorgemiddelde (-1,47)
P/B Ratio13,97
EV/EBITDAN/A
Dividend YieldN/A

Koershistorie

Financiële Trends

Sectorvergelijking

vs Manufacturing sector mediaan (1364 peers)
Metriek Aandeel Sector Mediaan
P/E -0,9 -1,5
P/B 14,0 1,6
ROE % — -53,5
Net Margin % -646,8 -41,5
Rev Growth 5Y % -38,6 1,8
D/E — 0,3

All Fundamental Metrics
Growth
Revenue Growth (1Y) -81,32% Revenue Growth (3Y) -58,85%
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) -38,61% Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 8,14 M Net Income (TTM) -52,66 M
ROE N/A ROA -172,54%
Gross Margin 2,42% Operating Margin -173,30%
Net Margin -646,80% Free Cash Flow (TTM) -11,44 M
ROIC N/A FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 0,80
Interest Coverage -7,70 Asset Turnover 0,27
Working Capital -4,69 M Tangible Book Value 3,52 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -0,93 Forward P/E N/A
P/B Ratio 13,97 P/S Ratio 6,05
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -23,24%
Market Cap 49,23 M Enterprise Value 36,17 M
Per Share
EPS (Diluted TTM) -2,02 Revenue / Share 0,02
FCF / Share -0,03 OCF / Share -0,03
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue N/A FCF Conversion 21,73%
SBC-Adj. FCF -16,94 M Growth Momentum -42,71

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 6,53 M 34,98 M 38,59 M 54,66 M 46,01 M
Net Income -45,01 M -168.000,0 -22,77 M -39,32 M 3,39 M
EPS (Diluted) -2,13 -0,10 -32,29 -1,34 0,14
Gross Profit 1,53 M 12,99 M 11,80 M 15,26 M 15,37 M
Operating Income -11,41 M -5,97 M -21,18 M -38,78 M -17,28 M
EBITDA — — — — —
R&D Expenses — 100.000,0 100.000,0 500.000,0 500.000,0
SG&A Expenses 12,93 M 18,96 M 24,44 M 32,46 M 28,51 M
D&A 31.000,0 130.000,0 1,68 M 1,69 M 1,66 M
Interest Expense 628.000,0 467.000,0 1,35 M -551.000,0 -3,22 M
Income Tax — 9.000,0 2.000,0 -18.000,0 37.000,0

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 8,40 M 15,80 M 16,74 M 38,68 M 74,66 M
Total Liabilities 8,00 M 7,15 M 13,76 M 17,15 M 16,79 M
Shareholders' Equity 407.000,0 8,65 M 2,98 M 21,53 M 57,88 M
Total Debt 35,99 M 2,58 M 5,45 M 11,61 M 10,27 M
Cash & Equivalents 1,31 M 3,07 M 4,46 M 3,17 M 21,73 M
Current Assets 8,13 M 15,00 M 16,23 M 27,53 M 43,92 M
Current Liabilities 3,54 M 7,15 M 13,69 M 5,58 M 7,34 M